Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mallmann

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Immunity|February 18, 2014
Transcriptome-based network analysis reveals a spectrum model of human macrophage activationJia Xue, Susanne V Schmidt, Jil Sander, et al.
Oncoimmunology|November 17, 2022
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cellsNiels Werchau, Bettina Kotter, Elvira Criado-Moronati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2017
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group InitiativeTine Cuppens, Daniela Annibali, An Coosemans, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Immunity|February 18, 2014
Transcriptome-based network analysis reveals a spectrum model of human macrophage activationJia Xue, Susanne V Schmidt, Jil Sander, et al.
Oncoimmunology|November 17, 2022
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cellsNiels Werchau, Bettina Kotter, Elvira Criado-Moronati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2017
Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group InitiativeTine Cuppens, Daniela Annibali, An Coosemans, et al.
Pageof 7